银华心质混合C(017724)利润分配表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 收入 |
286,479,828.80 |
26,830,917.06 |
-44,142,339.51 |
-116,960,874.96 |
| 利息合计 |
52,490.85 |
32,950.23 |
183,519.87 |
111,272.06 |
| 其中:存款利息收入 |
52,490.85 |
32,950.23 |
183,519.87 |
111,272.06 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
225,923,346.06 |
-8,866,601.11 |
-111,454,319.33 |
-116,870,862.46 |
| 其中:股票投资收益 |
220,802,542.74 |
-12,421,584.87 |
-124,194,405.55 |
-122,492,897.29 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
10,535.35 |
667.40 |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
5,110,267.97 |
3,554,316.36 |
12,740,086.22 |
5,622,034.83 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
60,415,116.49 |
35,654,228.61 |
67,107,167.85 |
-209,710.18 |
| 其他收入 |
88,875.40 |
10,339.33 |
21,292.10 |
8,425.62 |
| 费用 |
10,793,049.39 |
6,075,725.52 |
13,697,691.78 |
7,287,540.03 |
| 管理人报酬 |
7,727,400.83 |
4,356,181.33 |
9,849,623.76 |
5,225,815.15 |
| 基金托管费 |
1,287,900.19 |
726,030.20 |
1,641,604.03 |
870,969.23 |
| 销售服务费 |
1,578,521.08 |
895,041.46 |
2,025,433.08 |
1,075,994.49 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
199,227.29 |
98,472.53 |
181,030.91 |
114,761.16 |
| 利润总额 |
275,686,779.41 |
20,755,191.54 |
-57,840,031.29 |
-124,248,414.99 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年